Cited by 26Down syndrome and intellectual disability researchNeurogenesis and neuroplasticity mechanismsGenetics and Neurodevelopmental Disorders

Neuroanatomical alterations in higher-order thalamic nuclei of fetuses with Down syndrome

Open access
Stagni, Fiorenza, Giacomini, Andrea, Emili, Marco, Uguagliati, Beatrice, Bonasoni, Maria Paola, Bartesaghi, Renata, Guidi, Sandra·2020·Clinical Neurology and Neurosurgery

Abstract

Objectives Down syndrome (DS) is a genetic condition characterized by cognitive disability starting from infancy. Children with DS exhibit deficits in several cognitive domains, including executive function, i.e., a set of cognitive processes that heavily depend on higher-order thalamic nuclei. The goal of this study was to establish whether executive function-related thalamic nuclei of fetuses with DS exhibit neuroanatomical alterations that may contribute to the defects in higher-order control processes seen in children with DS. Patients and methods In brain sections from fetuses with DS and control fetuses (gestational week 17-22), we evaluated the cellularity in the mediodorsal nucleus (MD), the centromedian nucleus (CM), and the parafascicular nucleus (PF) of the thalamus and the density of proliferating cells in the third ventricle. Results We found that all three nuclei had a notably reduced cell density. This defect was associated with a reduced density of proliferating cells in the third ventricle, suggesting that the reduced cellularity in the MD, CM, and PF of fetuses with DS was due to neurogenesis impairment. The separate evaluation of projection neurons and interneurons in the MD, CM, and PF showed that in fetuses with DS the density of projection neurons was reduced, with no changes in interneuron density. Conclusion This study provides novel evidence for DS-linked cellularity alterations in the MD, CM, and PF and suggests that altered signal processing in these nuclei may be involved in the impairment in higher-order control processes observed in individuals with DS starting from infancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clineuro.2020.105870

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Analyses of fetal brain tissue indicate that there are fewer proliferating cells, as measured by expression of the cell cycle marker Ki67 and of cyclin proteins, in the germinal zones of the hippocampus and cortex in Down syndrome.

    “Analyses of fetal brain tissue indicate that there are fewer proliferating cells, as measured by their expression of the cell cycle marker Ki67 and of cyclin proteins, in the germinal zones of the hippocampus and cortex in DS40,42–44,47,50,64.”

    From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [64]

    Section 4.1 (page not supplied) reports earlier findings of reduced neural-progenitor pools in fetal Down syndrome hippocampal and temporal regions. Section 3.4 reports fewer Ki-67-positive cells in this study, but measures the third-ventricle zone and thalamic region, not hippocampal or cortical germinal zones. Our copy does not report cyclin-protein measurements for the claimed regions. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The presence of fewer cycling cells and the reduced number of progenitors both support the suggestion that neurogenesis is reduced during development in Down syndrome, although these data do not distinguish between slower progenitor proliferation or premature progenitor cell cycle exit.

    “Together, the presence of fewer cycling cells and the reduced number of progenitors both support the suggestion that neurogenesis is reduced during development in DS, although these data do not distinguish between slower progenitor proliferation or premature progenitor cell cycle exit.”

    From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [64]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • A third study found no difference in the density of interneurons in thalamic nuclei of fetuses (17-21 weeks gestation) with Down syndrome compared to those without.

    “A third study also found no difference in the density of interneurons in thalamic nuclei of fetuses (17–21 weeks gestation) with DS compared to those without (Stagni et al., 2020).”

    From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Stagni et al., 2020

    The Abstract reports no change in interneuron density in the mediodorsal, centromedian, and parafascicular thalamic nuclei of fetuses with Down syndrome compared with controls. However, the Abstract and §2.1 (Subjects) give the gestational range as 17–22 weeks, not 17–21 weeks. Page numbers were not available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Reductions in the number of proliferating neural progenitor cells in the dentate gyrus, germinal matrix of the lateral ventricle, and third ventricle have been observed in tissue derived from fetuses diagnosed with Down syndrome (17-21 weeks gestation) prior to the initial observations of volumetric changes.

    “Reductions in the number of proliferating neural progenitor cells (NPCs) in the dentate gyrus, germinal matrix of the lateral ventricle, and third ventricle have all been observed in tissue derived from fetuses diagnosed with DS (17–21 weeks gestation) prior to the initial observations of volumetric changes (Contestabile et al., 2007; Stagni et al., 2020).”

    From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Stagni et al., 2020

    Section 3.4 (page unavailable) reports fewer proliferating cells in the third-ventricle ventricular zone of fetuses with Down syndrome, although that difference did not reach statistical significance. Section 4.1 (page unavailable) also reports earlier findings in the dentate gyrus. The paper does not establish the claimed reduction in the lateral-ventricle germinal matrix or that these findings preceded the initial observations of volumetric changes; its study included fetuses at 17–22, rather than specifically 17–21, gestational weeks. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • During 17-21 weeks gestation, fewer neurons were found in the hippocampus, cerebellum, and multiple thalamic nuclei in fetuses with Down syndrome.

    “During the same time period (17–21 weeks gestation) fewer neurons were found in the hippocampus (Guidi et al., 2008), cerebellum (Guidi et al., 2011), and multiple thalamic nuclei (Stagni et al., 2020).”

    From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Stagni et al., 2020

    Section 4.1 reports fewer neurons in the mediodorsal, centromedian, and parafascicular thalamic nuclei of fetuses with Down syndrome. Section 2.1 describes the study's gestational range as 17–22 weeks, not 17–21 weeks; the hippocampus and cerebellum are attributed to other citations in the citing sentence. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stagni, F., Giacomini, A., Emili, M., Uguagliati, B., Bonasoni, M. P., Bartesaghi, R., & Guidi, S.
Affiliations
  • University of Bologna (IT)
  • Azienda Sanitaria Unità Locale di Reggio Emilia (IT)
Corresponding author
  • Bartesaghi, Renata
  • Guidi, Sandra
Venue
Clinical Neurology and Neurosurgery
Publisher
Elsevier BV
Published
2020-07
Volume
194
Pages
105870
ISSN
0303-8467 (ISSN-L)
OpenAlex
W3028063070
Cited by
26
References
3
Citations by year
2026: 4 · 2025: 4 · 2024: 8 · 2023: 3 · 2022: 7
FWCI
1.87
Type
journal article
Language
en
Open access
Locations
  • Clinical Neurology and Neurosurgery (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
Funders
Università di Bologna (RFO2017)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
Down syndrome, thalamus, mediodorsal nucleus, centromedian nucleus, parafascicular nucleus, executive function, fetal brain development, cell density, proliferating cells, third ventricle, projection neurons, interneurons, cognitive disability
MeSH terms
Adult, Cell Count, Down Syndrome, Female, Fetus, Gestational Age, Humans, Interneurons, Neuroglia, Neurons, Pregnancy, Thalamic Nuclei, Apoptosis, Third Ventricle, Mediodorsal Thalamic Nucleus, Intralaminar Thalamic Nuclei, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review